| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |